Baxter International

BAX
Delayed Nyse - 01/24 10:00:28 pm
90.78USD
-0.35%
Prev.91.1000
Open91.2400
High91.4700
Low90.5100
Volume1 610 778
Financials
Sales 2019 11 321 M
EBIT 2019 2 081 M
Net income 2019 1 677 M
Debt 2019 1 566 M
Yield 2019 0,90%
P/E ratio 2019 28,7x
P/E ratio 2020 25,7x
EV / Sales2019 4,23x
EV / Sales2020 4,04x
Capitalization 46 348 M
Company
Baxter International specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows:
- kidney dialysis drugs and equipment (51.7%);
- systems for delivering medications and...
Sector :
Medical Equipment, Supplies & Distribution - NEC
Calendar :
2020-02-26 Presentation
Trading Rating :
Investor Rating :
Latest news
01/24FINAL DEADLINE TODAY : ROSEN, A LEADING LAW FIRM, Reminds Baxter International Inc. Investors of Important January 24th Deadline in Securities Class Action
BU
01/20BAXTER 96 HOUR DEADLINE ALERT : Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Baxter International Inc. - BAX
BU
01/16THE LAW OFFICES OF FRANK R. CRUZ : Announces the Filing of a Securities Class Action on Behalf of Baxter International, Inc. Investors (BAX)
BU
01/15BAXTER INTERNATIONAL : to Present at the 9th Annual SVB Leerink Healthcare Conference
PU
01/15BAXTER INTERNATIONAL : to Present at the 9th Annual SVB Leerink Global Healthcare Conference
BU
01/15THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation on Behalf of Baxter International Inc. Investors (BAX)
BU
01/13BAXTER INTERNATIONAL : Shares Rise as 4Q Sales Top Views
DJ
01/13BAXTER INTERNATIONAL : Says 4Q Sales Will Top Street Views But Postpones Report
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance91,291,297,3
Spread/Res.-0,42%-0,42%-6,7%
Spread/Supp.5,7%10%10%
Support85,982,282,5